NHAS
Novo Holdings A/S Portfolio holdings
AUM
$1.42B
1-Year Return
12.08%
This Quarter Return
+3%
1 Year Return
+12.08%
3 Year Return
+99.82%
5 Year Return
+98.46%
10 Year Return
+612.59%
AUM
$1.85B
AUM Growth
+$405M
(+28%)
Cap. Flow
+$427M
Cap. Flow
% of AUM
23.03%
Top 10 Holdings %
Top 10 Hldgs %
65.27%
Holding
41
New
6
Increased
10
Reduced
6
Closed
3
Top Buys
| 1 |
Vanguard Total Stock Market ETF
VTI
|
$278M |
| 2 |
TEM
Tempus AI, Inc. Class A Common Stock
TEM
|
$143M |
| 3 |
Edgewise Therapeutics
EWTX
|
$114M |
| 4 |
Merus
MRUS
|
$39.9M |
| 5 |
Celldex Therapeutics
CLDX
|
$31.5M |
Top Sells
| 1 |
Edgewell Personal Care
EPC
|
$116M |
| 2 |
ASML
ASML
|
$50.3M |
| 3 |
Insmed
INSM
|
$36.1M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
$19.8M |
| 5 |
Inspire Medical Systems
INSP
|
$14.1M |
Sector Composition
| 1 | Healthcare | 53.05% |
| 2 | Technology | 16.21% |
| 3 | Financials | 9.98% |
| 4 | Communication Services | 2.26% |
| 5 | Consumer Discretionary | 1.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Brookfield Asset Management
BAM
$94B
| $23.9M | 1.29% |
627,207
| – | – |
|
27
Rocket Pharmaceuticals
RCKT
$354M
| $23.7M | 1.28% |
1,100,000
+50,000
| +5% | +$1.08M |
|
28
Lexeo Therapeutics
LXEO
$271M
| $23.3M | 1.25% |
1,450,500
-187,798
| -11% | -$3.01M |
|
|
BPMC
29
DELISTED
Blueprint Medicines
BPMC
| $18.9M | 1.02% |
175,000
-183,626
| -51% | -$19.8M |
|
30
Kyverna Therapeutics
KYTX
$170M
| $13.1M | 0.71% |
1,750,000
+1,050,000
| +150% | +$7.88M |
|
|
MORF
31
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $12.8M | 0.69% |
+375,000
| New | +$12.8M |
|
|
VERV
32
DELISTED
Verve Therapeutics
VERV
| $11.7M | 0.63% |
2,400,000
+400,000
| +20% | +$1.95M |
|
33
Metagenomi
MGX
$71.7M
| $7.34M | 0.4% |
1,800,000
+60,825
| +3% | +$248K |
|
34
IO Biotech
IOBT
$128M
| $5.18M | 0.28% |
4,429,449
-658,809
| -13% | -$771K |
|
35
AbCellera Biologics
ABCL
$1.26B
| $3.34M | 0.18% |
1,126,915
| – | – |
|
36
Marqeta
MQ
$2.76B
| $2.42M | 0.13% |
441,558
| – | – |
|
37
Galecto
GLTO
$3.99M
| $1.18M | 0.06% |
99,912
| – | – |
|
38
Spero Therapeutics
SPRO
$121M
| $610K | 0.03% |
468,902
| – | – |
|
|
39
Edgewell Personal Care
EPC
$1.09B
| – | – |
-6,344,430
| Closed | -$116M |
|
|
40
Inspire Medical Systems
INSP
$2.56B
| – | – |
-65,524
| Closed | -$14.1M |
|
41
Treace Medical Concepts
TMCI
$453M
| – | – |
-360,000
| Closed | -$4.7M |
|